drugset / Trial / NCT01907061

Acute Renal Failure Post Liver Transplantation

NCT01907061

Completed 30 enrolled Baylor Research Institute
RandomizedSingle-groupOpen-labelTreatment

Summary

Trial to test the effect of administering N-acetylcysteine on cytokines and markers of oxidant stress and the incidence of acute renal failure post liver tranplant

Timeline

Start
2007-07
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-acetylcysteine Small molecule 600 mg Intravenous

Indications